Insiders' Blog
Sponsored by: Subscribe to EasyStockAlerts.com Now & Get The News Before Everyone Else!
Icahn's Icahn Capital Shows New 6.3M Share Stake in Amylin Pharma (AMLN)
More News related to AMLN
- David Moenning's Daily State of the Markets: 7/22
- Amylin Pharma (AMLN) Added To Goldman Sachs Conviction Buy List; Gilead (GILD) Removed
- Amylin Pharmaceuticals (AMLN) Tops Q2 EPS by 2c
- Amylin Pharmaceuticals Reports Second Quarter Financial Results
- Amylin Pharmaceuticals to Webcast Second Quarter Results
More News related to Insiders' Blog
- UPDATE: Wachovia's (WB) New CEO Steel Buys One Million Shares
- ETF Movers 7/23: Coal ETF (KOL), Gold Miners ETF (GDX) Sell-Off, Homebuilders (XHB) Higher
- Earnings Preview of the Day 7/23: Amazon.com (AMZN)
- AmTech Previews MEMC Electronic (WFR) Q2 Earnings
- Intuitive Surgical (ISRG) Bulls Have Reason To Cheer After Strong Quarter
Carl Icahn's Icahn Capital latest 13F shows he built a stake in Amylin Pharmaceuticals Inc. (Nasdaq: AMLN).
Icahn showed a new 6,339,653 share stake in AMLN.
Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States.
Related Categories
Insider TradesInsiders' Blog
Stocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
